Aclaris Therapeutics
ACRS
ACRS
103 hedge funds and large institutions have $163M invested in Aclaris Therapeutics in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 40 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.75% less ownership
Funds ownership: 84.84% → 79.09% (-5.8%)
35% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 40
Holders
103
Holding in Top 10
2
Calls
$33K
Puts
–
Top Buyers
| 1 | +$2.23M | |
| 2 | +$1.39M | |
| 3 | +$1.25M | |
| 4 |
Morgan Stanley
New York
|
+$936K |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$651K |
Top Sellers
| 1 | -$7.58M | |
| 2 | -$3.98M | |
| 3 | -$1M | |
| 4 |
D.E. Shaw & Co
New York
|
-$745K |
| 5 |
Two Sigma Advisers
New York
|
-$722K |